New Delhi [India], Following the worldwide withdrawal of the AstraZeneca COVID-19 vaccine, Aam Aadmi Party leader Saurabh Bhardwaj on Wednesday questioned the Center as to why it allowed the Covishield vaccine while most European countries It was banned due to its side effects. Saurabh said, "Even when most of the European countries banned the Covishield vaccine in March 2021 due to side effects, the Indian government continued to use this vaccine. Now facing criticism from the courts in the UK, he has The vaccine has been withdrawn across the board." AstraZeneca withdrew its vaccine after the company admitted for the first time in court documents that it could cause a rare and dangerous side effect, according to a report in British newspaper The Telegraph. AstraZeneca has announced that the vaccine is being removed from the markets for commercial reasons.It further said that the vaccine is no longer being manufactured or supplied, having been replaced by updated vaccines that fight the new variants. The application to withdraw the vaccine was made on March 5 and became effective on May 7. The vaccine can no longer be used. Following the decision to withdraw the company's "marketing authorisation" in the EU. Similar applications will be submitted in the coming months in the UK and other countries that have given the green light to the vaccine, called Vaxzevria.In recent months, Vaxjavria has come under scrutiny due to a very rare side effect that causes blood clots and low blood platelet counts. In court documents, AstraZeneca admitted to the High Court in February that the vaccine "can, in very rare cases, cause TTS." AstraZeneca has stressed that the decision to withdraw the vaccine is not related to this case or the admission. It can cause TTS and while AstraZeneca dismissed the timing as pure coincidence last week, AstraZeneca reiterated its commitment to patient safety while emphasizing the overall safety profile of the vaccine, The Telegraph reported. Despite these rare events, the pharmaceutical company said that extensive clinical trial data and real-world evidence consistently supports this. Vaccine safety and efficacy. Regulatory agencies around the world continue to stress that the benefits of vaccination outweigh the risks of such extremely rare side effects.